Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

Applying Recent A1C Recommendations in Clinical Practice

Research_Review_Special_Report_2023_Update_of_NZSSD_Type_2_Guidelines by WBOP PHO - Issuu

Weight loss and benefits for cardiovascular disease (CVD)

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update - ScienceDirect

Toujeo® (insulin glargine) injection 300 Units/mL vs Tresiba

Frontiers Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study

Diabetes Canada Clinical Practice Guidelines

Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes – touchENDOCRINOLOGY

Frontiers Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study

Profile of ipragliflozin for treating type 2 diabetes

Applying Recent A1C Recommendations in Clinical Practice

Frontiers Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study